Taking peopleNo phase
Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Next Biomedical Co., Ltd.
- Trial code
- NCT06930677
- Record updated
- 19 November 2025
- Original description
Study in patients with knee osteoarthritis treated by embolization using NBGM200Read full original descriptionShow less
A Prospective, Single-arm, Multinational, Multi-center, Clinical Study to Evaluate the Performance and Safety of Musculoskeletal Embolization Using NBGM200 in Patients With Knee Degenerative Osteoarthritis
Study in patients with knee osteoarthritis treated by embolization using NBGM200
Inclusion: Osteoarthritis proven by MR-imaging.
Exclusion: Current local infection; Life expectancy less than 6 months.